Zev M. Munk

574 total citations
14 papers, 410 citations indexed

About

Zev M. Munk is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Immunology and Allergy. According to data from OpenAlex, Zev M. Munk has authored 14 papers receiving a total of 410 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Physiology, 10 papers in Pulmonary and Respiratory Medicine and 8 papers in Immunology and Allergy. Recurrent topics in Zev M. Munk's work include Asthma and respiratory diseases (12 papers), Respiratory and Cough-Related Research (8 papers) and Allergic Rhinitis and Sensitization (8 papers). Zev M. Munk is often cited by papers focused on Asthma and respiratory diseases (12 papers), Respiratory and Cough-Related Research (8 papers) and Allergic Rhinitis and Sensitization (8 papers). Zev M. Munk collaborates with scholars based in United States, Austria and Belgium. Zev M. Munk's co-authors include James M. Seltzer, Theodore F. Reiss, Ji Zhang, Sumiko Shingo, Leonard C. Altman, Gary N. Gross, Eli O. Meltzer, Kenneth M. Kral, Henry Milgrom and John W. Georgitis and has published in prestigious journals such as Journal of Allergy and Clinical Immunology, Clinical Therapeutics and Annals of Allergy Asthma & Immunology.

In The Last Decade

Zev M. Munk

13 papers receiving 384 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Zev M. Munk United States	11	338	241	184	40	31	14	410
E Martí-Guadaño Spain	9	308 0.9×	106 0.4×	290 1.6×	66 1.6×	16 0.5×	9	388
G Riario-Sforza Italy	10	168 0.5×	89 0.4×	167 0.9×	10 0.3×	22 0.7×	40	327
Yoshihisa Ishiura Japan	13	290 0.9×	248 1.0×	22 0.1×	15 0.4×	23 0.7×	37	413
Jessica Rajan United States	4	245 0.7×	115 0.5×	130 0.7×	6 0.1×	88 2.8×	6	427
E. Philpot United States	20	936 2.8×	336 1.4×	973 5.3×	281 7.0×	87 2.8×	51	1.1k
Wisam Al-Ramli Canada	7	141 0.4×	113 0.5×	21 0.1×	6 0.1×	111 3.6×	9	364
Jillian C. Bensko United States	9	304 0.9×	132 0.5×	139 0.8×	5 0.1×	41 1.3×	16	407
A Corrias Italy	9	121 0.4×	75 0.3×	117 0.6×	4 0.1×	21 0.7×	17	272
Fang Yi China	11	208 0.6×	240 1.0×	11 0.1×	49 1.2×	27 0.9×	40	318
L.A. Danielson United States	8	97 0.3×	37 0.2×	66 0.4×	5 0.1×	37 1.2×	10	516

Countries citing papers authored by Zev M. Munk

Since Specialization

Citations

This map shows the geographic impact of Zev M. Munk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zev M. Munk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zev M. Munk more than expected).

Fields of papers citing papers by Zev M. Munk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zev M. Munk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zev M. Munk. The network helps show where Zev M. Munk may publish in the future.

Co-authorship network of co-authors of Zev M. Munk

This figure shows the co-authorship network connecting the top 25 collaborators of Zev M. Munk. A scholar is included among the top collaborators of Zev M. Munk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zev M. Munk. Zev M. Munk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Wolfe, James, Anthony R. Rooklin, James J. Grady, et al.. (2000). Comparison of once- and twice-daily dosing of fluticasone propionate 200 micrograms per day administered by Diskus device in patients with asthma treated with or without inhaled corticosteroids. Journal of Allergy and Clinical Immunology. 105(6). 1153–1161. 30 indexed citations

Milgrom, Henry, et al.. (1999). Comparison of ipratropium bromide 0.03% with beclomethasone dipropionate in the treatment of perennial rhinitis in children. Annals of Allergy Asthma & Immunology. 83(2). 105–111. 44 indexed citations

DeAbate, C. Andrew, et al.. (1999). Effectiveness of short-course therapy (5 days) with grepafloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis. Clinical Therapeutics. 21(1). 172–188. 18 indexed citations

Altman, Leonard C., Zev M. Munk, James M. Seltzer, et al.. (1998). A placebo-controlled, dose-ranging study of montelukast, a cysteinyl leukotriene–receptor antagonist. Journal of Allergy and Clinical Immunology. 102(1). 50–56. 127 indexed citations

Meltzer, Eli O., H.Alice Orgel, John W. Georgitis, et al.. (1997). Ipratropium Nasal Spray in Children with Perennial Rhinitis. Annals of Allergy Asthma & Immunology. 78(5). 485–491. 23 indexed citations

Munk, Zev M., Gary N. Gross, Frank C. Hampel, & Paul H. Ratner. (1997). Preseasonal, Once Daily Triamcinolone Acetonide Nasal Aerosol for Seasonal Allergic Rhinitis. Annals of Allergy Asthma & Immunology. 78(3). 325–331. 14 indexed citations

Munk, Zev M., et al.. (1996). Efficacy and Safety of Triamcinolone Acetonide Aqueous Nasal Spray in Patients with Seasonal Allergic Rhinitis. Annals of Allergy Asthma & Immunology. 77(4). 277–281. 30 indexed citations

Wasserman, Stephen I., Gary N. Gross, William F. Schoenwetter, et al.. (1996). A 12-Week Dose-Ranging Study of Fluticasone Propionate Powder in the Treatment of Asthma. Journal of Asthma. 33(4). 265–274. 59 indexed citations

Prenner, Bruce M., Paul Chervinsky, Frank C. Hampel, et al.. (1996). Double-strength beclomethasone dipropionate (84 μg/spray) aqueous nasal spray in the treatment of seasonal allergic rhinitis. Journal of Allergy and Clinical Immunology. 98(2). 302–308. 24 indexed citations

10.

Busse, William W., Peter S. Creticos, Jerry Dolovich, et al.. (1996). A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial Comparing the Efficacy and Tolerability of Levocabastine-Oxymetazoline Nasal Spray with Levocabastine and Oxymetazoline Alone in the Symptomatic Treatment of Seasonal Allergic Rhinitis. American Journal of Rhinology. 10(2). 105–112. 1 indexed citations

11.

Noonan, Michael, Zev M. Munk, Paul Chervinsky, et al.. (1996). 273 Low doses of inhaled fluticasone propionate (FP) reduce bronchial hyperresponsiveness (BHR). Journal of Allergy and Clinical Immunology. 97(1). 251–251. 1 indexed citations

12.

Munk, Zev M., David S. Pearlman, David F. Graft, et al.. (1994). Intranasal Fluticasone Propionate Is Effective and Well-Tolerated in Adolescents with Seasonal Allergic Rhinitis. Pediatric Asthma Allergy & Immunology. 8(1). 39–46. 13 indexed citations

13.

Lumry, William R., Richard C. Ahrens, Robert J. Dockhorn, et al.. (1991). 56 Fluticasone propionate is safe and effective for children with seasonal allergic rhinitis. Journal of Allergy and Clinical Immunology. 87(1). 152–152. 3 indexed citations

14.

Munk, Zev M., et al.. (1977). Pheochromocytoma presenting with pulmonary edema and hyperamylasemia.. PubMed. 116(4). 357–9. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact